HealthCor Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

HealthCor Management’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-86,930	Closed	-$1.48M	–	107
2020 Q4	$1.48M	Buy	+86,930	New	+$1.09M	0.06%	53
2018 Q1	–	Sell	-101,000	Closed	-$2.21M	–	57
2017 Q4	$2.21M	Sell	101,000 -909,930	-90%	-$29.3M	0.07%	37
2017 Q3	$41.4M	Buy	+1,010,930	New	+$31.7M	1.39%	26
2014 Q2	–	Sell	-416,944	Closed	-$8.2M	–	73
2014 Q1	$8.2M	Sell	416,944 -783,056	-65%	-$13.3M	0.49%	40
2013 Q4	$20.1M	Buy	+1,200,000	New	+$14.9M	1.22%	27

Other funds holding FPRX

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

HealthCor Management's FPRX Position: Q1 2021 in Review

HealthCor Management sold out of Five Prime Therapeutics, Inc. (FPRX) in Q1 2021, closing a stake of 86,930 shares — an estimated $1.48M sold.

HealthCor Management first reported a position in FPRX in Q4 2013 and held it in 5 quarters. The position peaked at $41.4M in Q3 2017. 147 funds tracked by Wall St. Rank hold FPRX as of Q1 2021.

HealthCor Management reported no remaining Five Prime Therapeutics, Inc. position as of Q1 2021 after selling out during the quarter.
HealthCor Management sold 86,930 Five Prime Therapeutics, Inc. shares in Q1 2021, an estimated $1.48M.
HealthCor Management first reported a position in Five Prime Therapeutics, Inc. in Q4 2013 and held it in 5 quarters.
HealthCor Management's Five Prime Therapeutics, Inc. position peaked at $41.4M in Q3 2017.
147 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q1 2021.

Based on HealthCor Management's 13F filing for Q1 2021, filed 17 May 2021.